Over-expression of semaphorin4d, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer

International Journal of Molecular Sciences

Volumn 13, Issue 10, 2012, Pages 13264-13274

  Chen, Ying ^a   Zhang, Lei ^a   Pan, Yi ^a   Ren, Xiubao ^a   Hao, Quan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

HIF 1; Ovarian cancer; Prognosis; Semaphorin4D; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; SEMAPHORIN4D; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; SEMAPHORIN; VASCULOTROPIN A;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; OVARY CARCINOMA; OVERALL SURVIVAL; PHENOTYPIC VARIATION; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROGNOSIS;

ADULT; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; SEMAPHORINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867799225     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131013264     Document Type: Article

References (21)

1. Sakurai, A.; Doçi, C.L.; Gutkind, J.S. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 2012, 22, 23-32.
2. Carmeliet, P.; Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005, 436, 193-200.
3. Basile, J.R.; Castilho, R.M.; Williams, V.P.; Gutkind, J.S. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc. Natl. Acad. Sci. USA 2006, 103, 9017-9022.
4. Conrotto, P.; Valdembri, D.; Corso, S.; Serini, G.; Tamagnone, L.; Comoglio, P.M.; Bussolino, F.; Giordano, S. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005, 105, 4321-4329.
5. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 1990, 82, 4-6.
6. Lu, X.; Kang, Y. Hypoxia and hypoxia-inducible factors: Master regulators of metastasis. Clin. Cancer Res. 2010, 16, 5928-5935.
7. Wang, G.L.; Jiang, B.H.; Rue, E.A.; Semenza, G.L. Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 1995, 92, 5510-5514.
8. Vajkoczy, P.; Farhadi, M.; Gaumann, A.; Heidenreich, R.; Erber, R.; Wunder, A.; Tonn, J.C.; Menger, M.D.; Breier, G. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J. Clin. Invest. 2002, 109, 777-785.
9. Siebold, C.; Berrow, N.; Walter, T.S.; Harlos, K.; Owens, R.J.; Stuart, D.I.; Terman, J.R.; Kolodkin, A.L.; Pasterkamp, R.J.; Jones, E.Y. High-resolution structure of the catalytic region of MICAL (molecule interacting with CasL), a multidomain flavoenzyme-signaling molecule. Proc. Natl. Acad. Sci. USA 2005, 102, 16836-16841.
10. Sun, Q.; Zhou, H.; Binmadi, N.O.; Basile, J.R. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J. Biol. Chem. 2009, 284, 32066-32074.
11. Zhou, H.; Binmadi, N.O.; Yang, Y.H.; Proia, P.; Basile, J.R. Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. Angiogenesis 2012, 15, 391-407.
12. Zhou, H.; Yang, Y.H.; Binmadi, N.O.; Proia, P.; Basile, J.R. The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma. Exp. Cell Res. 2012, 318, 1685-1698.
13. Ozols, R.F.; Bookman, M.A.; Connolly, D.C.; Daly, M.B.; Godwin, A.K.; Schilder, R.J.; Xu, X.; Hamilton, T.C. Focus on epithelial ovarian cancer. Cancer Cell 2004, 5, 19-24.
14. Sopo, M.; Anttila, M.; Sallinen, H.; Tuppurainen, L.; Laurema, A.; Laidinen, S.; Hamalainen, K.; Tuunanen, P.; Koponen, J.K.; Kosma, V.M., et al. Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma. Int. J. Cancer 2012, 131, 2394-2401.
15. Semenza, G.L. Hypoxia-dinducible facor 1 (HIF-1) pathway. Sci. STKE 2007, 407, cm8.
16. Neufeld, G.; Cohen, T.; Gengrinovitch, S.; Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999, 13, 9-22.
17. Basile, J.R.; Barac, A.; Zhu, T.; Guan, K.L.; Gutkind, J.S. Class IV Semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res. 2004, 64, 5212-5224.
18. Mizukami, Y.; Kohgo, Y.; Chung, D.C. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin. Cancer Res. 2007, 13, 5670-5674.
19. Shimogai, R.; Kigawa, J.; Itamochi, H.; Iba, T.; Kanamori, Y.; Oishi, T.; Shimada, M.; Sato, S.; Kawaguchi, W.; Sato, S., et al. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer. Int. J. Gynecol. Cancer 2008, 18, 499-505.
20. Ch'ng, E.; Tomita, Y.; Zhang, B.; He, J.; Hoshida, Y.; Qiu, Y.; Morii, E.; Nakamichi, I.; Hamada, K.; Ueda, T., et al. Prognostic significance of CD100 expression in soft tissue sarcoma. Cancer 2007, 110, 164-172.
21. Bachtiary, B.; Schindl, M.; Pötter, R.; Dreier, B.; Knocke, T.H.; Hainfellner, J.A.; Horvat, R.; Birner, P. Cervical cancer prognosis in patients receiving radical radiotherapy for diminished response to radiotherapy and unfavorable over expression. Clin. Cancer Res. 2003, 9, 2234-2240.